Events
Zenith Capital Corp. announced that its Annual and Special Meeting of Shareholders is to be held Thursday, October 31, 2019 at Mount Royal University, Roderick Mah Centre for Continuous Learning – Ross Glen Hall, 4825 Mount Royal Gate SW, Calgary, Alberta.
CEOs Share Breakthroughs, Insights and Opportunities at “Think Asia, Think Hong Kong” Symposium
rfxcel, the global leader in supply chain track and trace solutions, will exhibit at this year’s CPhI Middle East & Africa conference in Abu Dhabi, United Arab Emirates.
Vivoryon Therapeutics AG, will publish its Half Year Results for 2019 on Thursday, August 29, 2019.
Emery Pharma and CP Lab Safety will be attending the American Chemical Society’s National Meeting & Expo in San Diego, California on August 25 – 27, 2019.
Diagnostica Stago, introduces the STA Workcell Max, a transformative specimen processing platform designed to meet the rigorous requirements of efficient hemostasis testing.
Fusion Antibodies plc, specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, confirms that the Annual Report and Accounts for the year ended 31 March 2019, the Notice of Annual General Meeting and a Form of Proxy will be posted to shareholders later.
Oxford Immunotec Global PLC announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial Officer, will be participating in two upcoming investor conferences.
Polyphor AG announced that it will host a Key Opinion Leader (KOL) breakfast meeting on novel approaches to the treatment of metastatic breast cancer on Friday, September 6, 2019 in New York City.
Assertio Therapeutics, Inc. announced that members of senior management will participate at the 17th Annual Morgan Stanley Global Healthcare Conference in a session scheduled for 11:45 a.m. ET, Tuesday, September 10, 2019 in New York, NY.
PRESS RELEASES